Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage By: CNBC.com News July 06, 2023 at 16:44 PM EDT Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage By: CNBC.com News July 06, 2023 at 16:44 PM EDT Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding. Read More >>